HAE Jun 2024 80.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

5.50

0.00

(0.00%)

At close: 11:39AM EDT

Loading interactive chart…

Zacks
Zacks Industry Outlook Highlights Boston Scientific, ResMed, Lantheus and Haemonetics
Boston Scientific, ResMed, Lantheus and Haemonetics are part of the Zacks Industry Outlook article.
Zacks
Haemonetics (HAE) Expands VASCADE Line With New Limited Launch
Haemonetics (HAE) expands its VASCADE portfolio with the limited market release of VASCADE MVP XL vascular closure device.
Zacks
4 Medical Product Stocks to Buy From a Recovering Industry
Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. BSX, RMD, LNTH and HAE are well-poised to gain from the favorable factors.